Every patient’s genetics affect how they respond to medication. Emyra translates complex genetic data into actionable insights, helping providers choose the safest and most effective drug or dose for each individual.

Tiny genetic differences can determine how quickly your body processes a medication, how well it works, or whether you’re more likely to experience side effects. Emyra helps clinicians identify these differences before prescribing — so treatment is tailored to you, not the average patient.

By bringing pharmacogenomics into everyday clinical practice, Emyra helps prevent costly adverse drug events, reduce trial-and-error prescribing, and improve patient satisfaction. Our platform enables health systems to deliver this level of personalized care seamlessly and at scale.

Emyra’s proprietary AI engine integrates pharmacogenomic data, medication history, and trusted clinical sources to generate real-time, evidence-based prescribing insights.

Our platform combines gene–drug interaction guidance with each patient’s unique genetic profile to help providers select the safest and most effective medications from the start,  eliminating trial-and-error prescribing and reducing the risk of adverse drug reactions.

Emyra makes precision medicine effortless. 

Our actionable intelligence is built directly into clinical workflows, empowering providers to make safer, more informed decisions without slowing down care. Through integration with leading EHRs, Emyra provides real-time medication recommendations, safety alerts, and dosing guidance—ensuring precision medicine happens naturally within existing workflows, not as an added step.

Emyra provides engaging, evidence-based resources that equip healthcare teams with the skills to apply precision medicine in practice and empower patients to take an active role in their health journey.

Together, we bridge the gap between genetic insight and everyday clinical use, creating a culture of precision medicine and empowerment.